The Positive Prognostic Value of Stress Echocardiography - AMPHIPOLIS STUDY
The Prognostic Value of Positive Stress Echocardiography and Its Relationship with Invasive Coronary Angiography: the AMPHIPOLIS Study
Hellenic Society of Cardiology
390 participants
Oct 1, 2024
OBSERVATIONAL
Conditions
Summary
This is a prospective, multicenter, observational study of patients with recent stress echocardiography positive for myocardial ischemia. Up to now 25 echocardiography labs form Greece and Cyprus have declared their intention to participate. The investigators will enroll 390 patients with a positive stress echo, who will undergo invasive coronary angiogram and then will be followed up for at least 6 months. The objectives are the following: 1. To assess the prognostic value of positive stress echo by monitoring for cardiovascular death and major adverse cardiovascular events (MACE) during the follow-up. 2. To investigate the relationship of stress echo findings with invasive coronary angiography anatomical findings. 3. The association of cardiovascular risk profile of participants with stress echo and coronary angiography findings.
Eligibility
Inclusion Criteria1
- Patients with recent stress echocardiography positive for any extent of myocardial ischemia
Exclusion Criteria5
- HFrEF requiring viability study.
- Any symptomatic valvular disease causing symptoms.
- Established or suspected cardiomyopathy.
- Concomitant chronic diseases reducing life expectancy (active cancer, severe liver impairment, auto-immune diseases etc).
- Recent acute coronary syndrome the last week.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06839755